aid: adagio-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/adagio-therapeutics.png
name: Adagio Therapeutics
description: 'Adagio Therapeutics is a clinical-stage biopharmaceutical company founded in 2020 to discover,
  develop, and commercialize antibody-based therapies for serious infectious diseases, with an initial
  focus on SARS-CoV-2 and other respiratory viruses. Its lead programs centered on monoclonal antibody
  candidates engineered for high potency and broad, evolution-resistant neutralization. The company was
  renamed Invivyd, Inc. in 2023 (Nasdaq: IVVD) and now advances antibody medicines such as PEMGARDA and
  the VYD2311 candidate. It was surfaced as a portfolio company of GV (Google Ventures) and added to the
  API Evangelist network. As a life-sciences therapeutics company it publishes no public developer API,
  SDK, or documentation surface; this profile captures corporate identity and policy links only.'
url: https://raw.githubusercontent.com/api-evangelist/adagio-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
x-former-name: Adagio Therapeutics
x-current-name: Invivyd, Inc.
x-no-api-surface: true
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Life Sciences
- Biotechnology
- Pharmaceuticals
- Antibody Therapeutics
- Infectious Diseases
apis: []
common:
- type: DomainSecurity
  url: security/adagio-therapeutics-domain-security.yml
- type: Website
  url: https://www.invivyd.com
- type: InvestorRelations
  url: https://investors.invivyd.com/
- type: TermsOfService
  url: https://www.invivyd.com/terms/
- type: PrivacyPolicy
  url: https://www.invivyd.com/privacy/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence